Esperance Anne Kreek Schaefer, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hepacivirus | 18 | 2022 | 1309 | 1.910 |
Why?
|
Hepatitis C, Chronic | 5 | 2019 | 1002 | 0.970 |
Why?
|
Hepatitis C | 10 | 2022 | 1493 | 0.950 |
Why?
|
Hepatitis B | 3 | 2022 | 631 | 0.800 |
Why?
|
Jaundice | 2 | 2019 | 86 | 0.770 |
Why?
|
Hepatitis D | 1 | 2019 | 18 | 0.760 |
Why?
|
Virus Replication | 9 | 2019 | 2524 | 0.760 |
Why?
|
Hepatitis B, Chronic | 1 | 2021 | 343 | 0.650 |
Why?
|
Hepatocytes | 6 | 2022 | 1242 | 0.630 |
Why?
|
Apolipoprotein B-100 | 1 | 2016 | 171 | 0.600 |
Why?
|
Virus Internalization | 2 | 2016 | 463 | 0.570 |
Why?
|
Pyrophosphatases | 1 | 2011 | 146 | 0.420 |
Why?
|
Interleukins | 2 | 2014 | 799 | 0.400 |
Why?
|
Hepatitis, Autoimmune | 1 | 2012 | 143 | 0.390 |
Why?
|
Lipase | 1 | 2011 | 313 | 0.380 |
Why?
|
Drugs, Investigational | 1 | 2012 | 235 | 0.370 |
Why?
|
Antiviral Agents | 6 | 2016 | 2768 | 0.360 |
Why?
|
Interferon-alpha | 4 | 2019 | 892 | 0.350 |
Why?
|
RNA, Viral | 1 | 2016 | 2847 | 0.340 |
Why?
|
Host-Pathogen Interactions | 2 | 2013 | 1482 | 0.320 |
Why?
|
Lipid Metabolism | 2 | 2013 | 1999 | 0.320 |
Why?
|
Liver Cirrhosis | 4 | 2022 | 1721 | 0.320 |
Why?
|
Transforming Growth Factor beta1 | 2 | 2022 | 647 | 0.270 |
Why?
|
Liver | 5 | 2022 | 7622 | 0.260 |
Why?
|
Octamer Transcription Factor-3 | 1 | 2022 | 243 | 0.200 |
Why?
|
Liver Diseases, Alcoholic | 1 | 2022 | 146 | 0.200 |
Why?
|
Viral Nonstructural Proteins | 2 | 2012 | 238 | 0.200 |
Why?
|
Hepatic Stellate Cells | 2 | 2022 | 120 | 0.200 |
Why?
|
Interferons | 3 | 2014 | 667 | 0.200 |
Why?
|
Fatty Acids | 2 | 2021 | 1741 | 0.190 |
Why?
|
Hepatitis B virus | 2 | 2022 | 444 | 0.180 |
Why?
|
Heroin Dependence | 1 | 2019 | 175 | 0.170 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 737 | 0.170 |
Why?
|
Gene Knockout Techniques | 2 | 2022 | 819 | 0.170 |
Why?
|
Oligodeoxyribonucleotides, Antisense | 1 | 2016 | 60 | 0.160 |
Why?
|
Hepatolenticular Degeneration | 1 | 2017 | 76 | 0.160 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 312 | 0.160 |
Why?
|
ras GTPase-Activating Proteins | 1 | 2016 | 99 | 0.150 |
Why?
|
Ribonucleoprotein, U5 Small Nuclear | 1 | 2015 | 5 | 0.140 |
Why?
|
Doxycycline | 1 | 2017 | 308 | 0.140 |
Why?
|
Peptide Elongation Factors | 1 | 2015 | 67 | 0.140 |
Why?
|
Liver Failure, Acute | 1 | 2017 | 174 | 0.140 |
Why?
|
Macrophage Activation | 1 | 2018 | 596 | 0.140 |
Why?
|
Ribonucleoproteins, Small Nuclear | 1 | 2014 | 70 | 0.140 |
Why?
|
Substance Abuse, Intravenous | 1 | 2019 | 480 | 0.130 |
Why?
|
STAT1 Transcription Factor | 2 | 2014 | 318 | 0.130 |
Why?
|
Spliceosomes | 1 | 2014 | 110 | 0.130 |
Why?
|
Minority Groups | 1 | 2021 | 1077 | 0.130 |
Why?
|
Endoribonucleases | 1 | 2016 | 219 | 0.130 |
Why?
|
Membrane Proteins | 1 | 2011 | 8072 | 0.130 |
Why?
|
Unfolded Protein Response | 1 | 2016 | 244 | 0.130 |
Why?
|
Gastric Mucosa | 1 | 2017 | 611 | 0.130 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2016 | 469 | 0.130 |
Why?
|
Duodenum | 1 | 2017 | 476 | 0.130 |
Why?
|
Liver Diseases | 2 | 2019 | 1246 | 0.120 |
Why?
|
Oligonucleotides | 1 | 2016 | 609 | 0.120 |
Why?
|
NF-kappa B | 3 | 2016 | 2563 | 0.120 |
Why?
|
Desmosterol | 1 | 2012 | 4 | 0.120 |
Why?
|
HIV | 2 | 2018 | 1489 | 0.120 |
Why?
|
Lipoproteins, VLDL | 1 | 2013 | 228 | 0.120 |
Why?
|
Gene Expression Regulation | 4 | 2021 | 12447 | 0.120 |
Why?
|
Cell Line | 6 | 2019 | 16657 | 0.120 |
Why?
|
Cyclophilins | 1 | 2012 | 53 | 0.120 |
Why?
|
MicroRNAs | 2 | 2019 | 3655 | 0.110 |
Why?
|
DEAD-box RNA Helicases | 1 | 2015 | 357 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Synthase | 1 | 2011 | 16 | 0.110 |
Why?
|
Deoxyribonucleases | 1 | 2012 | 205 | 0.110 |
Why?
|
Serine Proteinase Inhibitors | 1 | 2012 | 186 | 0.100 |
Why?
|
RNA Splicing | 1 | 2014 | 877 | 0.100 |
Why?
|
Transcriptional Activation | 1 | 2016 | 1849 | 0.090 |
Why?
|
Proteomics | 1 | 2022 | 3244 | 0.090 |
Why?
|
Viral Proteins | 1 | 2016 | 1967 | 0.090 |
Why?
|
Interferon Type I | 1 | 2012 | 498 | 0.090 |
Why?
|
Lactones | 1 | 2011 | 340 | 0.090 |
Why?
|
Receptors, Cell Surface | 1 | 2018 | 2913 | 0.090 |
Why?
|
Vascular Diseases | 1 | 2017 | 1154 | 0.090 |
Why?
|
Liver Function Tests | 2 | 2021 | 533 | 0.080 |
Why?
|
Humans | 27 | 2022 | 708843 | 0.080 |
Why?
|
Fatty Liver | 1 | 2013 | 718 | 0.080 |
Why?
|
Protease Inhibitors | 1 | 2011 | 830 | 0.080 |
Why?
|
Antigens, CD | 1 | 2018 | 4169 | 0.080 |
Why?
|
Drug Resistance, Viral | 1 | 2012 | 794 | 0.080 |
Why?
|
Antigens, Neoplasm | 1 | 2014 | 2003 | 0.080 |
Why?
|
Diagnosis, Differential | 2 | 2019 | 13274 | 0.070 |
Why?
|
Ultrasonography | 1 | 2019 | 5918 | 0.070 |
Why?
|
Mass Screening | 1 | 2021 | 5182 | 0.070 |
Why?
|
Intestinal Mucosa | 1 | 2017 | 3070 | 0.070 |
Why?
|
Immunologic Factors | 1 | 2015 | 1578 | 0.070 |
Why?
|
Transforming Growth Factor beta | 1 | 2013 | 1993 | 0.070 |
Why?
|
Cholesterol | 1 | 2013 | 2866 | 0.070 |
Why?
|
RNA, Small Interfering | 4 | 2016 | 3645 | 0.060 |
Why?
|
Autoantibodies | 1 | 2012 | 1976 | 0.060 |
Why?
|
Immunity, Innate | 1 | 2015 | 2937 | 0.060 |
Why?
|
Organic Anion Transporters, Sodium-Dependent | 1 | 2022 | 26 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2014 | 2060 | 0.050 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2022 | 154 | 0.050 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6562 | 0.050 |
Why?
|
Signal Transduction | 3 | 2014 | 23950 | 0.050 |
Why?
|
Cell Line, Tumor | 4 | 2022 | 16959 | 0.050 |
Why?
|
Disease Progression | 2 | 2021 | 13298 | 0.050 |
Why?
|
Stem Cells | 1 | 2012 | 3593 | 0.050 |
Why?
|
Symporters | 1 | 2022 | 366 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2017 | 6991 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2014 | 4044 | 0.040 |
Why?
|
Genes, Regulator | 1 | 2019 | 389 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3097 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2014 | 8638 | 0.040 |
Why?
|
Genotype | 1 | 2011 | 12863 | 0.040 |
Why?
|
Activating Transcription Factor 6 | 1 | 2016 | 28 | 0.040 |
Why?
|
Pyruvate Kinase | 1 | 2018 | 185 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8024 | 0.040 |
Why?
|
Interferon-Stimulated Gene Factor 3, gamma Subunit | 1 | 2014 | 9 | 0.040 |
Why?
|
eIF-2 Kinase | 1 | 2016 | 151 | 0.040 |
Why?
|
Middle Aged | 4 | 2019 | 213752 | 0.030 |
Why?
|
Ultrasonography, Doppler | 1 | 2017 | 466 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 3026 | 0.030 |
Why?
|
Puerperal Disorders | 1 | 2017 | 277 | 0.030 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1778 | 0.030 |
Why?
|
Actins | 1 | 2022 | 2191 | 0.030 |
Why?
|
United States | 1 | 2021 | 67165 | 0.030 |
Why?
|
Animals | 3 | 2021 | 170486 | 0.030 |
Why?
|
Time Factors | 2 | 2014 | 41038 | 0.030 |
Why?
|
Acetaminophen | 1 | 2017 | 540 | 0.030 |
Why?
|
HIV Infections | 1 | 2018 | 15538 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2016 | 1374 | 0.030 |
Why?
|
Proteome | 1 | 2022 | 1767 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2011 | 15485 | 0.030 |
Why?
|
Phosphorylation | 2 | 2014 | 8720 | 0.030 |
Why?
|
Male | 5 | 2022 | 349524 | 0.030 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2017 | 753 | 0.030 |
Why?
|
Abdomen | 1 | 2017 | 1094 | 0.030 |
Why?
|
Autophagy | 1 | 2019 | 1343 | 0.030 |
Why?
|
Chromatography, Affinity | 1 | 2011 | 575 | 0.020 |
Why?
|
Models, Biological | 2 | 2021 | 9907 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2011 | 17218 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1728 | 0.020 |
Why?
|
Protein Interaction Domains and Motifs | 1 | 2012 | 513 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2019 | 20170 | 0.020 |
Why?
|
Female | 6 | 2022 | 375205 | 0.020 |
Why?
|
Protein Binding | 2 | 2012 | 9639 | 0.020 |
Why?
|
Cell Movement | 1 | 2022 | 5489 | 0.020 |
Why?
|
Administration, Oral | 1 | 2017 | 3944 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2015 | 1482 | 0.020 |
Why?
|
Computational Biology | 1 | 2021 | 3568 | 0.020 |
Why?
|
Protein Interaction Mapping | 1 | 2012 | 639 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2138 | 0.020 |
Why?
|
Immunohistochemistry | 1 | 2021 | 11790 | 0.020 |
Why?
|
Metformin | 1 | 2013 | 800 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2017 | 2022 | 0.020 |
Why?
|
Treatment Outcome | 1 | 2012 | 61932 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9556 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3156 | 0.020 |
Why?
|
Mass Spectrometry | 1 | 2011 | 2244 | 0.020 |
Why?
|
Macrophages | 1 | 2018 | 5784 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2021 | 18375 | 0.010 |
Why?
|
Young Adult | 2 | 2018 | 55940 | 0.010 |
Why?
|
Alleles | 1 | 2012 | 7090 | 0.010 |
Why?
|
Biopsy | 1 | 2013 | 6766 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 11239 | 0.010 |
Why?
|
Adult | 3 | 2022 | 211041 | 0.010 |
Why?
|
Comorbidity | 1 | 2014 | 10339 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2014 | 13314 | 0.010 |
Why?
|
Genome, Human | 1 | 2012 | 4493 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2017 | 21194 | 0.010 |
Why?
|
Adolescent | 2 | 2017 | 84718 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2013 | 5405 | 0.010 |
Why?
|
Aged | 2 | 2018 | 161488 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39038 | 0.010 |
Why?
|
Mice | 1 | 2021 | 80876 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 71483 | 0.010 |
Why?
|
Mutation | 1 | 2012 | 29262 | 0.010 |
Why?
|